Sofinnova Investments as of Sept. 30, 2019
Portfolio Holdings for Sofinnova Investments
Sofinnova Investments holds 71 positions in its portfolio as reported in the September 2019 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Ascendis Pharma A S (ASND) | 9.7 | $107M | 1.1M | 96.32 | |
| Natera (NTRA) | 9.2 | $102M | 3.1M | 32.80 | |
| Amarin Corporation | 7.1 | $79M | 5.2M | 15.16 | |
| Nextcure (NXTC) | 7.0 | $78M | 2.5M | 30.85 | |
| Y Mabs Therapeutics | 5.0 | $55M | 2.1M | 26.06 | |
| Spark Therapeutics | 4.2 | $47M | 481k | 96.98 | |
| Principia Biopharma | 3.6 | $40M | 1.4M | 28.24 | |
| Obseva Sa | 3.6 | $40M | 4.7M | 8.33 | |
| Coherus Biosciences (CHRS) | 3.5 | $39M | 1.9M | 20.26 | |
| Merus N V (MRUS) | 3.2 | $35M | 2.0M | 17.82 | |
| Karuna Therapeutics Ord | 2.5 | $28M | 1.7M | 16.32 | |
| Select Sector Spdr Tr option | 2.4 | $27M | 300k | 90.13 | |
| Audentes Therapeutics | 2.4 | $26M | 934k | 28.09 | |
| Bristol Myers Squibb (BMY) | 2.2 | $24M | 478k | 50.71 | |
| Allergan | 2.0 | $23M | 134k | 168.29 | |
| Vertex Pharmaceuticals Incorporated (VRTX) | 1.9 | $21M | 122k | 169.41 | |
| Amgen (AMGN) | 1.6 | $18M | 92k | 193.52 | |
| Nucana Biomed ordinary shares | 1.6 | $17M | 2.4M | 7.24 | |
| Neurocrine Biosciences (NBIX) | 1.6 | $17M | 192k | 90.12 | |
| Nucana Plc american depositary shares | 1.5 | $16M | 2.3M | 7.24 | |
| Acceleron Pharma | 1.5 | $16M | 408k | 39.51 | |
| United Therapeutics Corporation (UTHR) | 1.4 | $16M | 194k | 79.76 | |
| Pfizer (PFE) | 1.3 | $15M | 411k | 35.93 | |
| Reata Pharmaceuticals Inc Cl A | 1.1 | $12M | 149k | 80.29 | |
| Reata Pharmaceuticals Inc cl a | 1.1 | $12M | 149k | 80.29 | |
| Iterum Therapeutics | 0.9 | $10M | 1.7M | 5.77 | |
| Halozyme Therapeutics (HALO) | 0.9 | $9.9M | 636k | 15.51 | |
| Tg Therapeutics (TGTX) | 0.9 | $9.7M | 1.7M | 5.62 | |
| Ptc Therapeutics I (PTCT) | 0.9 | $9.7M | 287k | 33.82 | |
| Chiasma | 0.7 | $8.1M | 1.6M | 4.95 | |
| Sarepta Therapeutics (SRPT) | 0.7 | $8.0M | 106k | 75.33 | |
| Kiniksa Pharmaceuticals | 0.7 | $7.9M | 923k | 8.51 | |
| Macrogenics (MGNX) | 0.7 | $7.4M | 582k | 12.76 | |
| Aimmune Therapeutics | 0.7 | $7.3M | 347k | 20.94 | |
| Entasis Therapeutics Holdings Ord | 0.6 | $7.0M | 1.2M | 5.96 | |
| Kadmon Hldgs | 0.6 | $6.6M | 2.6M | 2.52 | |
| Dermira | 0.6 | $6.3M | 990k | 6.39 | |
| Beigene Ltd call | 0.6 | $6.1M | 50k | 122.43 | |
| Fate Therapeutics (FATE) | 0.5 | $5.9M | 382k | 15.53 | |
| Myokardia | 0.5 | $5.9M | 114k | 52.15 | |
| BioMarin Pharmaceutical (BMRN) | 0.5 | $5.7M | 85k | 67.40 | |
| Amicus Therapeutics (FOLD) | 0.5 | $5.8M | 723k | 8.02 | |
| Dicerna Pharmaceuticals | 0.5 | $4.9M | 343k | 14.36 | |
| Akebia Therapeutics (AKBA) | 0.4 | $4.8M | 1.2M | 3.92 | |
| Zymeworks | 0.4 | $4.7M | 188k | 24.79 | |
| Heron Therapeutics (HRTX) | 0.4 | $4.2M | 227k | 18.51 | |
| Xbiotech (XBIT) | 0.3 | $3.8M | 359k | 10.46 | |
| Foamix Pharmaceuticals | 0.3 | $3.6M | 1.2M | 3.04 | |
| Otonomy | 0.3 | $3.4M | 1.4M | 2.39 | |
| Forty Seven | 0.3 | $3.3M | 519k | 6.42 | |
| Orchard Therapeutics Plc ads | 0.3 | $3.4M | 283k | 11.89 | |
| Calithera Biosciences | 0.3 | $3.0M | 965k | 3.09 | |
| ArQule | 0.3 | $2.8M | 393k | 7.17 | |
| Homology Medicines | 0.2 | $2.6M | 146k | 18.10 | |
| Cytokinetics (CYTK) | 0.2 | $2.4M | 211k | 11.38 | |
| Mirati Therapeutics | 0.2 | $2.4M | 31k | 77.88 | |
| Aclaris Therapeutics (ACRS) | 0.2 | $2.1M | 1.9M | 1.08 | |
| Align Technology (ALGN) | 0.2 | $1.8M | 10k | 180.97 | |
| Syndax Pharmaceuticals (SNDX) | 0.2 | $1.8M | 243k | 7.47 | |
| Kala Pharmaceuticals | 0.2 | $1.8M | 478k | 3.80 | |
| Portola Pharmaceuticals | 0.1 | $1.6M | 59k | 26.83 | |
| Syndax Pharmaceuticals | 0.1 | $1.5M | 200k | 7.47 | |
| Applied Therapeutics (APLT) | 0.1 | $1.6M | 142k | 10.98 | |
| BioCryst Pharmaceuticals (BCRX) | 0.1 | $1.5M | 517k | 2.86 | |
| Savara (SVRA) | 0.1 | $1.4M | 527k | 2.65 | |
| Synlogic | 0.1 | $1.3M | 575k | 2.29 | |
| Apellis Pharmaceuticals (APLS) | 0.1 | $1.2M | 50k | 24.08 | |
| Heron Therapeutics | 0.1 | $995k | 54k | 18.49 | |
| Sunesis Pharmaceuticals Inc Ne | 0.1 | $816k | 1.1M | 0.72 | |
| Syndax Pharmaceuticals Inc call | 0.1 | $746k | 100k | 7.46 | |
| Pds Biotechnology Ord (PDSB) | 0.0 | $482k | 143k | 3.38 |